Patents by Inventor Anuradha Sharma

Anuradha Sharma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230359457
    Abstract: A computer system is configured to identify a software development environment (SDE), and generate a first prebuild of the SDE. The computer system is further configured to obtain data associated with a plurality of elements that are related to a state of the SDE, and generate a first hash based on data associated with the plurality of elements. The computer system is also configured to identify a commit to the SDE and determine that the commit changed the state of SDE by obtaining data associated with the plurality of elements, generating a second hash based on the data, and determining that the second hash is different from the first hash. In response to determining that the first commit changed the state of the SDE, the computer system then generates a second prebuild of the SDE.
    Type: Application
    Filed: May 3, 2022
    Publication date: November 9, 2023
    Inventors: Anthony VAN DER HOORN, Srivatsn NARAYANAN, Anuradha SHARMA
  • Patent number: 10376456
    Abstract: The invention relates to aqueous, high active, self-preserving composition of mild surfactants which are used to create transparent liquid formulations with pH similar to skin's pH. More specifically, the composition comprise of sodium/potassium acyl isethionate of Formula I and mono potassium acyl glutamate of Formula II with solids content of at least 45 w/w, for personal care formulation that are ultra-mild, with skin pH and transparent.
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: August 13, 2019
    Assignee: GALAXY SURFACTANT
    Inventors: Arpit Wankhade, Bhagyesh Jagannath Sawant, Pritesh Mhatre, Nirmal Koshti, Pooja Vaidya Kshirsagar, Ashwini Ballal, Anuradha Sharma, Kumar Raunak
  • Publication number: 20190167554
    Abstract: The invention relates to aqueous, high active, self-preserving composition of mild surfactants which are used to create transparent liquid formulations with pH similar to skin's pH. More specifically, the composition comprise of sodium/potassium acyl isethionate of Formula I and mono potassium acyl glutamate of Formula II with solids content of at least 45% w/w, for personal care formulation that are ultra-mild, with skin pH and transparent.
    Type: Application
    Filed: August 3, 2015
    Publication date: June 6, 2019
    Inventors: Arpit WANKHADE, Bhagyesh Jagannath SAWANT, Pritesh MHATRE, Nirmal KOSHTI, Pooja Vaidya KSHIRSAGAR, Ashwini BALLAL, Anuradha SHARMA, Kumar RAUNAK
  • Patent number: 9668956
    Abstract: Low viscous, sulfate-free, cold-dispersible, aqueous pearlescent concentrates are prepared. The pearlizing concentrates of the instant invention are stable and remain pumpable and flowable during storage for longer duration.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: June 6, 2017
    Assignee: Galaxy Surfactants, Ltd.
    Inventors: Nirmal Koshti, Pritesh Rajaram Mhatre, Anuradha Sharma
  • Publication number: 20150335550
    Abstract: Low viscous, sulfate-free, cold-dispersible, aqueous pearlescent concentrates are prepared. The pearlizing concentrates of the instant invention are stable and remain pumpable and flowable during storage for longer duration.
    Type: Application
    Filed: May 19, 2015
    Publication date: November 26, 2015
    Inventors: Nirmal KOSHTI, Pritesh Rajaram MHATRE, Anuradha SHARMA
  • Publication number: 20090215710
    Abstract: The invention provides carbohydrate based compounds, methods of preparation, and compositions useful for modulating signaling through Toll-like receptors. The methods involve contacting a TLR-expressing cell with a carbohydrate based compound of the invention having a core structure comprising of one or more sugar moieties. The carbohydrate based compounds are useful for inhibiting immune stimulation involving TLR ligands, especially TLR4 and TLR2. The compounds also are suitable for inhibition of inflammatory conditions resulting from infections. The compounds have use in the treatment of inflammation, autoimmunity, allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer, and immunodeficiency.
    Type: Application
    Filed: September 23, 2008
    Publication date: August 27, 2009
    Applicant: RELIANCE LIFE SCIENCES PVT. LTD.
    Inventors: Shakti Upadhyay, Ashwani Sharma, Anuradha Sharma, Vikram Rajagopal, Praneel Datla, Akshaya Bellary, Shiva Prasad Singh